Tenured and Tenure-Track Faculty Positions in Preclinical and Translational Neurological Sciences

Rutgers Robert Wood Johnson Medical School

Department of Neurology and Institute for Neurological Therapeutics

The Department of Neurology and the RWJMS Institute for Neurological Therapeutics (RINT) invite applications for faculty positions to develop an innovative and interdisciplinary preclinical and translational research program in neurological diseases focused on neurodegenerative, neuroimmunologic and demyelinating disorders. Rank and tenure status will be determined based on candidate’s qualifications.

Under the leadership of RINT Founding Director, M. Maral Mouradian, MD, the mission of the Institute is to promote translational research for the objective of elucidating the molecular pathogenesis of chronic incurable neurological disorders and developing novel therapies. Current emphasis by Institute investigators includes Parkinson’s disease, other alpha-synucleinopathies, Alzheimer’s disease and Multiple Sclerosis. Ample opportunities exist for collaborations with basic and clinical faculty at Rutgers Robert Wood Johnson Medical School and with investigators across Rutgers Biomedical and Health Sciences, and Rutgers University’s departments of Medicinal Chemistry, Chemical Biology, and Bioengineering. An NIH funded T32 grant for Training in Translating Neuroscience to Therapeutics supports eligible graduate students, MD / PhD students and postdoctoral fellows. The Institute is housed in a state-of-the art research building located in the Piscataway, New Jersey campus. Rutgers provides competitive start-up packages and benefits. Additional information is available at:

http://rwjms.rutgers.edu/institutes/institute-for-neurological-therapeutics/mission

Applicants must hold a PhD, MD or MD / PhD, have at least 3 years of postdoctoral training in a relevant discipline, and a strong record of scholarly achievement. Candidates at the Associate and Full Professor level are expected to have an established federal grant portfolio. Priority will be given to outstanding applicants whose research focuses on preclinical and translational research that can lead to neurotherapeutics. Successful candidates will be expected to contribute to the training of postdoctoral fellows, graduate and undergraduate students, and maintain a productive extramurally funded research program.

Interested individuals are encouraged to apply by submitting a curriculum vitae, a brief statement of research plans, and the contact information of three individuals who will provide letters of reference to:

Lauren Kelly

Executive Assistant to the Director

RWJMS Institute for Neurological Therapeutics

lk496@rwjms.rutgers.edu